BioXcel Therapeutics Inc Live Stock Price Today, Share Analysis and Chart

Name: BioXcel Therapeutics Inc: Is Infosys Ltd. worth buying?
Item: BioXcel Therapeutics Inc
Rating: 0.81825
Author: Trendlyne DVM scores

about

BioXcel Therapeutics Inc is a clinical-stage biopharmaceutical company. The company is focused on drug development utilizing novel artificial intelligence (AI) to identify the next wave of medicines across neuroscience and immuno-oncology. The pipeli...

1.60 0.05 (3.23%)

80.20% Fall from 52W High

287.7K

XNAS Volume

High vol. this week

XNAS 11 Mar, 2026 12:02 PM (EDT)

Not Eligible

Expensive Valuation

3.5 / 100

Technically Bearish

29.2 / 100

1Yr Price target upside is 791%

4 analysts

BioXcel Therapeutics Inc Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

BioXcel Therapeutics Inc Live Stock Price Today, Share Analysis and Chart

BioXcel Therapeutics Inc is a clinical-stage biopharmaceutical company. The company is focused on drug development utilizing novel artificial intelligence (AI) to identify the next wave of medicines across neuroscience and immuno-oncology. The pipeli...

80.20% Fall from 52W High

High vol. this week

SWOT Analysis

BioXcel Therapeutics Inc Live Price Chart